US8785426 — Testosterone gel compositions and related methods
Method of Use · Assigned to Upsher Smith Laboratories LLC · Expires 2034-02-11 · 8y remaining
What this patent protects
This patent protects gel compositions containing testosterone for transdermal administration and related methods, excluding certain embodiments with the Hsieh enhancer.
USPTO Abstract
Described are gel compositions containing active pharmaceutical ingredient such as testosterone, solvent, and thickener, the gel compositions being useful for transdermal administration of the active ingredient to a patient, and related methods. Certain embodiments of the gel composition specifically exclude Hsieh enhancer.
Drugs covered by this patent
- Androgel (TESTOSTERONE) · Besins Hlthcare
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1531 |
— | Androgel |
U-1531 |
— | Androgel |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.